Clint Eastwood’s patent lawsuit dismissed

02-05-2019

Clint Eastwood’s patent lawsuit dismissed

Randy Miramontez / Shutterstock.com

A judge has dismissed actor Clint Eastwood’s motion to gain ownership over two diabetes patents currently assigned to Molecular Defenses Corporation (MDC).


Clint Eastwood, Molecular Defenses Corporation, 1988 Clinton Eastwood Trust, diabetes, glutathione, antioxidants, Antioxidant Pharmaceuticals Corporation

LSIPR